OSASEN SENSORES, S.L. of Derio at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

OSASEN SENSORES, S.L.

Parque Tecnológico de Bizkaia, Astondo Bidea, Edificio 612, 48160 Derio
Spain

This company is co-exhibitor of
Asoc. Basque Health Cluster

Hall map

MEDICA 2018 hall map (Hall 16): stand B31

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.04  Rapid tests in clinical chemistry

Rapid tests in clinical chemistry

Our products

Product category: Rapid tests in clinical chemistry

OSAXYL

OSASEN has developed the first product of the company: OSAXYL, a rapid, easy to use, non-invasive and cost effective tool applied for the accurate evaluation of the level of hypolactasia (lactose intolerance) by the detection of xylose in urine, using in combination with the diagnostic drug LacTEST® developed by VENTER PHARMA and commercialized by FERRER.

More Less

About us

Company details

OSASEN is a biotech company focused on the development and manufacture of Point of Care devices to assist in healthcare diagnostics. By working closely with the healthcare and pharmaceutical sector, we offer customized solutions that help to take efficient diagnostic decisions.

Our devices are based on electrochemical biosensors, which are fast, accurate, reliable and cost efficient tools that allow portable approaches for the prevention and monitoring of patients and therapies.

OSASEN is a spinoff launched by the company BIOLAN Microbiosensores and the Technology Centre CIDETEC in May 2015 as an opportunity to apply the know-how of both entities in biotechnology, electrochemistry and printed electronics to the healthcare sector.

OSASEN PoC devices comprise two main components:

1.     i) Disposable analytical platform, OSATEST, consisting of an electrochemical biosensing platform based on screen-printed electrodes (SPEs) functionalized with a biological recognition element, which allows an amperometric-enzymatic measurement through a specific biological recognition system.

2.     ii) BIOSENSOR OSASEN, a portable electronic reader able to translate the electrochemical signals obtained from the biological recognition process into an understandable value.

Based on both elements OSASEN has developed the first product of the company: OSAXYL, a rapid, easy to use, non-invasive and cost effective tool applied for the accurate evaluation of the level of hypolactasia (lactose intolerance) by the detection of xylose in urine, using in combination with the diagnostic drug LacTEST® developed by VENTER PHARMA and commercialized by FERRER.

More Less